Biological Activity of the Carrier as a Factor in Immunogen Design for Haptens
Autor: | Özlem Ertekin, Selma Öztürk, Esin Akcael, Harun Kocaağa |
---|---|
Rok vydání: | 2018 |
Předmět: |
0301 basic medicine
Immunogen Ovalbumin medicine.drug_class Pharmaceutical Science chemical and pharmacologic phenomena Transferrin receptor Monoclonal antibody Article Analytical Chemistry lcsh:QD241-441 Structure-Activity Relationship 03 medical and health sciences 0302 clinical medicine lcsh:Organic chemistry Drug Discovery medicine Animals Humans endocytosis Physical and Theoretical Chemistry chemistry.chemical_classification biology Spectrum Analysis Organic Chemistry Transferrin Antibody titer Antibodies Monoclonal hapten immunization transferrin receptor immunogen carrier protein 030104 developmental biology Biochemistry chemistry Chemistry (miscellaneous) 030220 oncology & carcinogenesis biology.protein Molecular Medicine Immunization Antibody Carrier Proteins Haptens Hapten |
Zdroj: | Molecules, Vol 23, Iss 11, p 2977 (2018) Molecules Volume 23 Issue 11 |
ISSN: | 1420-3049 |
DOI: | 10.3390/molecules23112977 |
Popis: | Immunoanalytical methods are frequently employed in the detection of hazardous small molecular weight compounds. However, antibody development for these molecules is a challenge, because they are haptens and cannot induce a humoral immune response in experimental animals. Immunogenic forms of haptens are usually prepared by conjugating them to a protein carrier which serves as an immune stimulator. However, the carrier is usually considered merely as a bulk mass, and its biological activity is ignored. Here, we induced an endocytic receptor, transferrin receptor, by selecting its ligand as a carrier protein to enhance antibody production. We conjugated aflatoxin, a potent carcinogenic food contaminant, to transferrin and evaluated its potential to stimulate antibody production with respect to ovalbumin conjugates. Transferrin conjugates induced aflatoxin-specific immune responses in the second immunization, while ovalbumin conjugates reached similar antibody titers after 5 injections. Monoclonal antibodies were successfully developed with mice immunized with either of the conjugates. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |